EMA — authorised 23 February 2001
- Marketing authorisation holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Status: approved
EMA authorised Tnkase on 23 February 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 23 February 2001.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH holds the EU marketing authorisation.